Saint John, IN, United States of America

Russell Dahl

This inventor holds 14 USPTO granted patents and 10 published patent applications and 1 EPO patent. Top assignees: Neurodon Corporation, Other. Active years: 2019-2024.

USPTO Granted Patents = 14 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

5 out of 5

Neurodon Corporation

patents

9 out of 834,411

Other

patents

Years Active: 2019-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12144806 - Quinolines that modulate SERCA and their use for treating disease (2024-11-19),

2. 11992487 - Quinolines that modulate SERCA and their use for treating disease (2024-05-28),

3. 11890279 - Quinolines that modulate SERCA and their use for treating disease (2024-02-06),

4. 11827626 - Quinolines that modulate SERCA and their use for treating disease (2023-11-28),

5. 11730729 - Quinolines that modulate SERCA and their use for treating disease (2023-08-22),

6. 11220498 - Neuroprotective aminothiazoles (2022-01-11),

7. 11213701 - Neuroprotective quinoline sulfonamides (2022-01-04),

8. 10800766 - Quinoline alkenes as cytoprotective agents (2020-10-13),

9. 10793558 - Quinoline oxadiazoles as cytoprotective agents (2020-10-06),

10. 10772881 - Quinolines that modulate SERCA and their use for treating disease (2020-09-15),

11. 10730843 - Quinoxalines useful as cytoprotective agents (2020-08-04),

12. 10730839 - Quinolines as cytoprotective agents (2020-08-04),

13. 10383868 - Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseases (2019-08-20),

14. 10383867 - Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders (2019-08-20),

Title: Unveiling the Innovative Journey of Inventor Russell Dahl

Introduction: Russell Dahl, a prolific inventor based in Saint John, IN (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With a total of 13 patents to his name, Dahl's work has garnered attention in the realms of treating various diseases, including neurological conditions and diabetes.

Latest Patents: Among his latest patents, one particularly noteworthy invention is the development of quinolines that modulate SERCA for treating neurological diseases, neurodegenerative disorders, and diabetes. Dahl's compounds of Formula I, along with the pharmaceutical compositions and methods of use associated with them, showcase his dedication to advancing medical treatments for a range of debilitating conditions.

Career Highlights: Russell Dahl has left an indelible mark on the industry through his work with reputable companies such as Neurodon Corporation. His innovative spirit and commitment to improving healthcare have propelled him to the forefront of pharmaceutical innovation. Dahl's 13 patents stand as a testament to his unwavering pursuit of scientific excellence and his desire to make a positive impact on society through his inventions.

Collaborations: Throughout his career, Russell Dahl has collaborated with esteemed professionals in the field of pharmaceuticals, sharing knowledge and expertise to push the boundaries of medical research. His partnerships with various individuals and organizations have led to the successful development of novel treatments and therapies that have the potential to transform healthcare practices globally.

Conclusion: Inventor Russell Dahl's remarkable journey underscores the power of innovation and perseverance in driving progress within the pharmaceutical industry. His numerous patents and groundbreaking inventions serve as a beacon of hope for those seeking advanced solutions to complex medical challenges. Dahl's work continues to inspire future generations of inventors and researchers to push the boundaries of scientific discovery in pursuit of a healthier and brighter tomorrow.